Literature DB >> 17940019

Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase.

Peter Hasselblatt1, Martina Rath, Vukoslav Komnenovic, Kurt Zatloukal, Erwin F Wagner.   

Abstract

Analysis of the molecular factors determining hepatocyte survival or death in response to inflammatory stimuli is essential for understanding the pathogenesis of inflammatory liver disease and for identifying novel therapeutic approaches. c-Jun N-terminal kinase (JNK) is a major mediator of cytokine-induced cell death during hepatitis, but the signaling pathways downstream of JNK remain less well defined. Here we show that the transcription factor c-Jun/AP-1, a prototypic target of JNK, is strongly expressed in the liver of patients with acute liver injury. The molecular function of c-Jun in inflammatory liver disease was analyzed in mice by using the Con A model of T cell-mediated hepatitis. Mice lacking c-Jun in hepatocytes display increased liver cell death and mortality upon Con A injection. This phenotype is caused by impaired expression of inducible nitric oxide synthase (nos2), a direct transcriptional target of c-Jun, and reduced production of hepatoprotective nitric oxide (NO). Moreover, increased hepatotoxicity in mutant mice is likely caused by hypoxia and oxidative stress and can be rescued pharmacologically by liver-specific NO delivery. These findings demonstrate that c-Jun/AP-1 is hepatoprotective during acute hepatitis by regulating nos2/NO expression and thus functionally antagonizes the cell death-promoting functions of JNK.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940019      PMCID: PMC2040484          DOI: 10.1073/pnas.0706272104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Radical causes of cancer.

Authors:  S Perwez Hussain; Lorne J Hofseth; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

2.  Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure.

Authors:  K Streetz; L Leifeld; D Grundmann; J Ramakers; K Eckert; U Spengler; D Brenner; M Manns; C Trautwein
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

3.  Distribution of nitric oxide synthase in normal and cirrhotic human liver.

Authors:  Lance McNaughton; Lakshmi Puttagunta; Maria Angeles Martinez-Cuesta; Norm Kneteman; Irvin Mayers; Redwan Moqbel; Qutayba Hamid; Marek W Radomski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

4.  Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in Con A-induced liver failure.

Authors:  K Streetz; B Fregien; J Plümpe; K Körber; S Kubicka; G Sass; S C Bischoff; M P Manns; G Tiegs; C Trautwein
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

5.  NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.

Authors:  E Hatano; B L Bennett; A M Manning; T Qian; J J Lemasters; D A Brenner
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

6.  Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice.

Authors:  G Sass; K Koerber; R Bang; H Guehring; G Tiegs
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

7.  Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT).

Authors:  A Behrens; K Sabapathy; I Graef; M Cleary; G R Crabtree; E F Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

8.  Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome.

Authors:  Laurie D DeLeve; Xiangdong Wang; Gary C Kanel; Yoshiya Ito; Nancy W Bethea; Margaret K McCuskey; Zoltan A Tokes; Jeffrey Tsai; Robert S McCuskey
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

9.  Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53.

Authors:  Robert Eferl; Romeo Ricci; Lukas Kenner; Rainer Zenz; Jean-Pierre David; Martina Rath; Erwin F Wagner
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

10.  IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha.

Authors:  Shin Maeda; Lufen Chang; Zhi-Wei Li; Jun-Li Luo; Hyam Leffert; Michael Karin
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

View more
  30 in total

Review 1.  MAPK signaling in inflammation-associated cancer development.

Authors:  Pengyu Huang; Jiahuai Han; Lijian Hui
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

2.  JUNB/AP-1 controls IFN-γ during inflammatory liver disease.

Authors:  Martin K Thomsen; Latifa Bakiri; Sebastian C Hasenfuss; Rainer Hamacher; Lola Martinez; Erwin F Wagner
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

3.  Targeted deletion of Jun/AP-1 in alveolar epithelial cells causes progressive emphysema and worsens cigarette smoke-induced lung inflammation.

Authors:  Narsa M Reddy; Suryanaraya Vegiraju; Ashley Irving; Bogdan C Paun; Irina G Luzina; Sergei P Atamas; Shyam Biswal; Navas-Acien Ana; Wayne Mitzner; Sekhar P Reddy
Journal:  Am J Pathol       Date:  2012-02       Impact factor: 4.307

4.  The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.

Authors:  C Trierweiler; B Hockenjos; K Zatloukal; R Thimme; H E Blum; E F Wagner; P Hasselblatt
Journal:  Cell Death Differ       Date:  2015-10-16       Impact factor: 15.828

5.  Activator protein-1 regulation of murine aldehyde dehydrogenase 1a1.

Authors:  N L Makia; I Amunom; K C Falkner; D J Conklin; S Surapureddi; J A Goldstein; R A Prough
Journal:  Mol Pharmacol       Date:  2012-06-26       Impact factor: 4.436

6.  Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers.

Authors:  Sebastian C Hasenfuss; Latifa Bakiri; Martin K Thomsen; Evan G Williams; Johan Auwerx; Erwin F Wagner
Journal:  Cell Metab       Date:  2014-01-07       Impact factor: 27.287

7.  Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase.

Authors:  Laura Gomez-Santos; Zigmund Luka; Conrad Wagner; Sara Fernandez-Alvarez; Shelly C Lu; Jose M Mato; Maria L Martinez-Chantar; Naiara Beraza
Journal:  Hepatology       Date:  2012-07-06       Impact factor: 17.425

Review 8.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

Review 9.  Signal integration by JNK and p38 MAPK pathways in cancer development.

Authors:  Erwin F Wagner; Angel R Nebreda
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

10.  Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin.

Authors:  Lihua Min; Yuan Ji; Latifa Bakiri; Zhixin Qiu; Jin Cen; Xiaotao Chen; Lingli Chen; Harald Scheuch; Hai Zheng; Lunxiu Qin; Kurt Zatloukal; Lijian Hui; Erwin F Wagner
Journal:  Nat Cell Biol       Date:  2012-10-07       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.